nodes	percent_of_prediction	percent_of_DWPC	metapath
Loperamide—CYP2C8—Cyclosporine—focal segmental glomerulosclerosis	0.218	0.368	CbGbCtD
Loperamide—ABCB1—Cyclosporine—focal segmental glomerulosclerosis	0.148	0.249	CbGbCtD
Loperamide—CYP2D6—Cyclosporine—focal segmental glomerulosclerosis	0.139	0.234	CbGbCtD
Loperamide—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.0884	0.149	CbGbCtD
Loperamide—POMC—kidney—focal segmental glomerulosclerosis	0.0136	0.151	CbGeAlD
Loperamide—CALM2—endothelium—focal segmental glomerulosclerosis	0.0092	0.102	CbGeAlD
Loperamide—CALM1—endothelium—focal segmental glomerulosclerosis	0.00916	0.102	CbGeAlD
Loperamide—OPRD1—kidney—focal segmental glomerulosclerosis	0.00748	0.0831	CbGeAlD
Loperamide—CALM3—nephron tubule—focal segmental glomerulosclerosis	0.00537	0.0596	CbGeAlD
Loperamide—CALM3—cortex of kidney—focal segmental glomerulosclerosis	0.00459	0.051	CbGeAlD
Loperamide—CALM2—nephron tubule—focal segmental glomerulosclerosis	0.00421	0.0468	CbGeAlD
Loperamide—CALM1—nephron tubule—focal segmental glomerulosclerosis	0.00419	0.0466	CbGeAlD
Loperamide—CALM2—kidney—focal segmental glomerulosclerosis	0.0037	0.0412	CbGeAlD
Loperamide—CALM1—kidney—focal segmental glomerulosclerosis	0.00369	0.041	CbGeAlD
Loperamide—CALM2—cortex of kidney—focal segmental glomerulosclerosis	0.00361	0.0401	CbGeAlD
Loperamide—CALM1—cortex of kidney—focal segmental glomerulosclerosis	0.00359	0.0399	CbGeAlD
Loperamide—CYP2B6—nephron tubule—focal segmental glomerulosclerosis	0.00313	0.0348	CbGeAlD
Loperamide—CYP2C8—kidney—focal segmental glomerulosclerosis	0.00307	0.0341	CbGeAlD
Loperamide—CYP2B6—kidney—focal segmental glomerulosclerosis	0.00275	0.0306	CbGeAlD
Loperamide—CYP3A4—kidney—focal segmental glomerulosclerosis	0.00208	0.0231	CbGeAlD
Loperamide—CYP2D6—kidney—focal segmental glomerulosclerosis	0.00205	0.0227	CbGeAlD
Loperamide—ABCB1—nephron tubule—focal segmental glomerulosclerosis	0.00167	0.0186	CbGeAlD
Loperamide—Bullous eruption—Cyclosporine—focal segmental glomerulosclerosis	0.00161	0.156	CcSEcCtD
Loperamide—ABCB1—kidney—focal segmental glomerulosclerosis	0.00147	0.0164	CbGeAlD
Loperamide—ABCB1—cortex of kidney—focal segmental glomerulosclerosis	0.00143	0.0159	CbGeAlD
Loperamide—Altered state of consciousness—Cyclosporine—focal segmental glomerulosclerosis	0.00138	0.133	CcSEcCtD
Loperamide—Dermatitis bullous—Cyclosporine—focal segmental glomerulosclerosis	0.000483	0.0468	CcSEcCtD
Loperamide—Anaphylactoid reaction—Cyclosporine—focal segmental glomerulosclerosis	0.000477	0.0462	CcSEcCtD
Loperamide—Abdominal pain upper—Cyclosporine—focal segmental glomerulosclerosis	0.000421	0.0408	CcSEcCtD
Loperamide—Abdominal distension—Cyclosporine—focal segmental glomerulosclerosis	0.000401	0.0389	CcSEcCtD
Loperamide—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000315	0.0305	CcSEcCtD
Loperamide—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000313	0.0303	CcSEcCtD
Loperamide—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.000274	0.0265	CcSEcCtD
Loperamide—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.000254	0.0246	CcSEcCtD
Loperamide—CALM2—Hemostasis—TRPC6—focal segmental glomerulosclerosis	0.000238	0.000776	CbGpPWpGaD
Loperamide—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	0.000238	0.000775	CbGpPWpGaD
Loperamide—CALM3—Platelet activation, signaling and aggregation—FN1—focal segmental glomerulosclerosis	0.000238	0.000774	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.000236	0.00077	CbGpPWpGaD
Loperamide—OPRD1—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000236	0.000768	CbGpPWpGaD
Loperamide—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.000235	0.0228	CcSEcCtD
Loperamide—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000234	0.0226	CcSEcCtD
Loperamide—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.000231	0.0224	CcSEcCtD
Loperamide—CALM2—Platelet activation, signaling and aggregation—FN1—focal segmental glomerulosclerosis	0.00023	0.000749	CbGpPWpGaD
Loperamide—CALM1—Platelet activation, signaling and aggregation—FN1—focal segmental glomerulosclerosis	0.00023	0.000749	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.000228	0.000744	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000228	0.000743	CbGpPWpGaD
Loperamide—OPRK1—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.000227	0.000741	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.000227	0.00074	CbGpPWpGaD
Loperamide—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.000227	0.022	CcSEcCtD
Loperamide—POMC—Metabolism—ALB—focal segmental glomerulosclerosis	0.000226	0.000738	CbGpPWpGaD
Loperamide—CALM3—Immune System—PIAS1—focal segmental glomerulosclerosis	0.000226	0.000737	CbGpPWpGaD
Loperamide—OPRK1—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.000226	0.000736	CbGpPWpGaD
Loperamide—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000222	0.0215	CcSEcCtD
Loperamide—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00022	0.0213	CcSEcCtD
Loperamide—OPRD1—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.00022	0.000717	CbGpPWpGaD
Loperamide—CALM1—Immune System—PIAS1—focal segmental glomerulosclerosis	0.000219	0.000713	CbGpPWpGaD
Loperamide—CALM2—Immune System—PIAS1—focal segmental glomerulosclerosis	0.000219	0.000713	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.000217	0.000707	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000217	0.000707	CbGpPWpGaD
Loperamide—ABCB1—Allograft Rejection—TGFB1—focal segmental glomerulosclerosis	0.000215	0.000702	CbGpPWpGaD
Loperamide—OPRM1—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.00021	0.000685	CbGpPWpGaD
Loperamide—OPRK1—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000207	0.000673	CbGpPWpGaD
Loperamide—CALM3—Hemostasis—GNAQ—focal segmental glomerulosclerosis	0.000206	0.000671	CbGpPWpGaD
Loperamide—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.000202	0.0195	CcSEcCtD
Loperamide—CYP2C8—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.000201	0.000655	CbGpPWpGaD
Loperamide—OPRD1—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.0002	0.000651	CbGpPWpGaD
Loperamide—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.0002	0.0193	CcSEcCtD
Loperamide—CALM1—Hemostasis—GNAQ—focal segmental glomerulosclerosis	0.000199	0.000649	CbGpPWpGaD
Loperamide—CALM2—Hemostasis—GNAQ—focal segmental glomerulosclerosis	0.000199	0.000649	CbGpPWpGaD
Loperamide—CALM3—Platelet activation, signaling and aggregation—SERPINE1—focal segmental glomerulosclerosis	0.000198	0.000644	CbGpPWpGaD
Loperamide—CALM3—Platelet activation, signaling and aggregation—ALB—focal segmental glomerulosclerosis	0.000197	0.000643	CbGpPWpGaD
Loperamide—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000196	0.019	CcSEcCtD
Loperamide—CACNA1A—Metabolism—ALB—focal segmental glomerulosclerosis	0.000196	0.000638	CbGpPWpGaD
Loperamide—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.000196	0.0189	CcSEcCtD
Loperamide—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.000194	0.0188	CcSEcCtD
Loperamide—OPRK1—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000193	0.000628	CbGpPWpGaD
Loperamide—OPRM1—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.000192	0.000626	CbGpPWpGaD
Loperamide—CALM2—Platelet activation, signaling and aggregation—SERPINE1—focal segmental glomerulosclerosis	0.000191	0.000623	CbGpPWpGaD
Loperamide—CALM1—Platelet activation, signaling and aggregation—SERPINE1—focal segmental glomerulosclerosis	0.000191	0.000623	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.000191	0.000622	CbGpPWpGaD
Loperamide—CALM2—Platelet activation, signaling and aggregation—ALB—focal segmental glomerulosclerosis	0.000191	0.000622	CbGpPWpGaD
Loperamide—CALM1—Platelet activation, signaling and aggregation—ALB—focal segmental glomerulosclerosis	0.000191	0.000622	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.00019	0.000618	CbGpPWpGaD
Loperamide—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000185	0.018	CcSEcCtD
Loperamide—OPRM1—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000183	0.000598	CbGpPWpGaD
Loperamide—OPRD1—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000183	0.000595	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000182	0.000593	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000181	0.00059	CbGpPWpGaD
Loperamide—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.00018	0.0174	CcSEcCtD
Loperamide—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000179	0.0174	CcSEcCtD
Loperamide—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.000177	0.000577	CbGpPWpGaD
Loperamide—OPRK1—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000175	0.000571	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000175	0.000569	CbGpPWpGaD
Loperamide—CALM3—Immune System—MYH9—focal segmental glomerulosclerosis	0.000168	0.000546	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—CD79A—focal segmental glomerulosclerosis	0.000167	0.000545	CbGpPWpGaD
Loperamide—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.000167	0.0162	CcSEcCtD
Loperamide—OPRD1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000166	0.00054	CbGpPWpGaD
Loperamide—OPRM1—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000163	0.000531	CbGpPWpGaD
Loperamide—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.000163	0.0158	CcSEcCtD
Loperamide—CALM2—Immune System—MYH9—focal segmental glomerulosclerosis	0.000162	0.000528	CbGpPWpGaD
Loperamide—CALM1—Immune System—MYH9—focal segmental glomerulosclerosis	0.000162	0.000528	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—CD79A—focal segmental glomerulosclerosis	0.000162	0.000528	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—CD79A—focal segmental glomerulosclerosis	0.000162	0.000528	CbGpPWpGaD
Loperamide—ABCB1—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	0.000162	0.000527	CbGpPWpGaD
Loperamide—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.00016	0.0155	CcSEcCtD
Loperamide—OPRK1—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.00016	0.000522	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.00016	0.00052	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000159	0.000517	CbGpPWpGaD
Loperamide—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.000155	0.015	CcSEcCtD
Loperamide—OPRD1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000152	0.000496	CbGpPWpGaD
Loperamide—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.00015	0.0145	CcSEcCtD
Loperamide—OPRM1—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000148	0.000482	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.000146	0.000477	CbGpPWpGaD
Loperamide—OPRK1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000145	0.000474	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000145	0.000474	CbGpPWpGaD
Loperamide—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.000144	0.014	CcSEcCtD
Loperamide—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000143	0.0138	CcSEcCtD
Loperamide—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000143	0.0138	CcSEcCtD
Loperamide—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000142	0.0138	CcSEcCtD
Loperamide—CALM1—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.000141	0.000461	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.000141	0.000461	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.000141	0.000461	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.000141	0.000458	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000139	0.000453	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.000137	0.000446	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.000137	0.000446	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—CD40LG—focal segmental glomerulosclerosis	0.000136	0.000445	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.000136	0.000443	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.000136	0.000443	CbGpPWpGaD
Loperamide—OPRM1—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000135	0.000441	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000135	0.00044	CbGpPWpGaD
Loperamide—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.000135	0.013	CcSEcCtD
Loperamide—CALM3—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.000134	0.000438	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000134	0.000437	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000133	0.000435	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—CD40LG—focal segmental glomerulosclerosis	0.000132	0.00043	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—CD40LG—focal segmental glomerulosclerosis	0.000132	0.00043	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.00013	0.000424	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.00013	0.000424	CbGpPWpGaD
Loperamide—CALM3—Platelet activation, signaling and aggregation—TGFB1—focal segmental glomerulosclerosis	0.000125	0.000407	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000123	0.0004	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	0.000123	0.0004	CbGpPWpGaD
Loperamide—CALM3—Hemostasis—FN1—focal segmental glomerulosclerosis	0.000122	0.000399	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000122	0.000398	CbGpPWpGaD
Loperamide—CALM3—Hemostasis—NOS2—focal segmental glomerulosclerosis	0.000121	0.000394	CbGpPWpGaD
Loperamide—CALM2—Platelet activation, signaling and aggregation—TGFB1—focal segmental glomerulosclerosis	0.000121	0.000393	CbGpPWpGaD
Loperamide—CALM1—Platelet activation, signaling and aggregation—TGFB1—focal segmental glomerulosclerosis	0.000121	0.000393	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.00012	0.00039	CbGpPWpGaD
Loperamide—CALM2—Hemostasis—FN1—focal segmental glomerulosclerosis	0.000118	0.000386	CbGpPWpGaD
Loperamide—CALM1—Hemostasis—FN1—focal segmental glomerulosclerosis	0.000118	0.000386	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.000118	0.000385	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000118	0.000384	CbGpPWpGaD
Loperamide—CALM2—Hemostasis—NOS2—focal segmental glomerulosclerosis	0.000117	0.000381	CbGpPWpGaD
Loperamide—CALM1—Hemostasis—NOS2—focal segmental glomerulosclerosis	0.000117	0.000381	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000114	0.000373	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.000114	0.000372	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.000114	0.000372	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000114	0.00037	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000113	0.000367	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.00011	0.000358	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.00011	0.000358	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000108	0.000353	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000108	0.000352	CbGpPWpGaD
Loperamide—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	0.000106	0.000346	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000106	0.000345	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	0.000105	0.000342	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000105	0.000341	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000105	0.000341	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000103	0.000337	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000103	0.000336	CbGpPWpGaD
Loperamide—CALM3—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000103	0.000335	CbGpPWpGaD
Loperamide—CALM3—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	0.000102	0.000332	CbGpPWpGaD
Loperamide—CALM3—Hemostasis—ALB—focal segmental glomerulosclerosis	0.000102	0.000331	CbGpPWpGaD
Loperamide—CALM3—Immune System—CD79A—focal segmental glomerulosclerosis	0.000102	0.000331	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.0001	0.000327	CbGpPWpGaD
Loperamide—CALM1—Metabolism—LIPC—focal segmental glomerulosclerosis	9.96e-05	0.000324	CbGpPWpGaD
Loperamide—CALM2—Metabolism—LIPC—focal segmental glomerulosclerosis	9.96e-05	0.000324	CbGpPWpGaD
Loperamide—CALM2—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	9.86e-05	0.000321	CbGpPWpGaD
Loperamide—CALM1—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	9.86e-05	0.000321	CbGpPWpGaD
Loperamide—CALM1—Hemostasis—ALB—focal segmental glomerulosclerosis	9.84e-05	0.000321	CbGpPWpGaD
Loperamide—CALM2—Hemostasis—ALB—focal segmental glomerulosclerosis	9.84e-05	0.000321	CbGpPWpGaD
Loperamide—CALM2—Immune System—CD79A—focal segmental glomerulosclerosis	9.82e-05	0.00032	CbGpPWpGaD
Loperamide—CALM1—Immune System—CD79A—focal segmental glomerulosclerosis	9.82e-05	0.00032	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	9.79e-05	0.000319	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	9.51e-05	0.00031	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—CTGF—focal segmental glomerulosclerosis	9.31e-05	0.000303	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	9.16e-05	0.000299	CbGpPWpGaD
Loperamide—CALM3—Metabolism—CTGF—focal segmental glomerulosclerosis	9.06e-05	0.000295	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	9.05e-05	0.000295	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—LIPC—focal segmental glomerulosclerosis	8.95e-05	0.000292	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	8.86e-05	0.000289	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	8.86e-05	0.000289	CbGpPWpGaD
Loperamide—CALM2—Metabolism—CTGF—focal segmental glomerulosclerosis	8.76e-05	0.000286	CbGpPWpGaD
Loperamide—CALM1—Metabolism—CTGF—focal segmental glomerulosclerosis	8.76e-05	0.000286	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	8.74e-05	0.000285	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	8.59e-05	0.00028	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—GNAQ—focal segmental glomerulosclerosis	8.58e-05	0.000279	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	8.48e-05	0.000276	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	8.35e-05	0.000272	CbGpPWpGaD
Loperamide—CALM3—Metabolism—GNAQ—focal segmental glomerulosclerosis	8.35e-05	0.000272	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	8.3e-05	0.000271	CbGpPWpGaD
Loperamide—CALM3—Immune System—CD40LG—focal segmental glomerulosclerosis	8.27e-05	0.00027	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	8.08e-05	0.000263	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	8.08e-05	0.000263	CbGpPWpGaD
Loperamide—CALM1—Metabolism—GNAQ—focal segmental glomerulosclerosis	8.08e-05	0.000263	CbGpPWpGaD
Loperamide—CALM2—Metabolism—GNAQ—focal segmental glomerulosclerosis	8.08e-05	0.000263	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	8.05e-05	0.000262	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	8.03e-05	0.000262	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	8.03e-05	0.000262	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	8.03e-05	0.000262	CbGpPWpGaD
Loperamide—CALM1—Immune System—CD40LG—focal segmental glomerulosclerosis	8e-05	0.000261	CbGpPWpGaD
Loperamide—CALM2—Immune System—CD40LG—focal segmental glomerulosclerosis	8e-05	0.000261	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	7.93e-05	0.000259	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—CTGF—focal segmental glomerulosclerosis	7.88e-05	0.000257	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—LIPC—focal segmental glomerulosclerosis	7.8e-05	0.000254	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	7.6e-05	0.000248	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	7.53e-05	0.000245	CbGpPWpGaD
Loperamide—CALM3—Disease—LPL—focal segmental glomerulosclerosis	7.5e-05	0.000244	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	7.36e-05	0.00024	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	7.36e-05	0.00024	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—LIPC—focal segmental glomerulosclerosis	7.35e-05	0.000239	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—GNAQ—focal segmental glomerulosclerosis	7.26e-05	0.000237	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	7.26e-05	0.000236	CbGpPWpGaD
Loperamide—CALM2—Disease—LPL—focal segmental glomerulosclerosis	7.25e-05	0.000236	CbGpPWpGaD
Loperamide—CALM1—Disease—LPL—focal segmental glomerulosclerosis	7.25e-05	0.000236	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	6.98e-05	0.000227	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—CTGF—focal segmental glomerulosclerosis	6.87e-05	0.000224	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	6.75e-05	0.00022	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	6.75e-05	0.00022	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	6.71e-05	0.000219	CbGpPWpGaD
Loperamide—ABCB1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	6.67e-05	0.000217	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	6.6e-05	0.000215	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—CTGF—focal segmental glomerulosclerosis	6.47e-05	0.000211	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—LPL—focal segmental glomerulosclerosis	6.45e-05	0.00021	CbGpPWpGaD
Loperamide—CALM3—Hemostasis—TGFB1—focal segmental glomerulosclerosis	6.43e-05	0.00021	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	6.38e-05	0.000208	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—GNAQ—focal segmental glomerulosclerosis	6.33e-05	0.000206	CbGpPWpGaD
Loperamide—CALM3—Metabolism—LPL—focal segmental glomerulosclerosis	6.28e-05	0.000205	CbGpPWpGaD
Loperamide—CALM2—Hemostasis—TGFB1—focal segmental glomerulosclerosis	6.22e-05	0.000203	CbGpPWpGaD
Loperamide—CALM1—Hemostasis—TGFB1—focal segmental glomerulosclerosis	6.22e-05	0.000203	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	6.18e-05	0.000201	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	6.18e-05	0.000201	CbGpPWpGaD
Loperamide—CALM2—Metabolism—LPL—focal segmental glomerulosclerosis	6.08e-05	0.000198	CbGpPWpGaD
Loperamide—CALM1—Metabolism—LPL—focal segmental glomerulosclerosis	6.08e-05	0.000198	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—GNAQ—focal segmental glomerulosclerosis	5.96e-05	0.000194	CbGpPWpGaD
Loperamide—CALM3—Disease—NOS2—focal segmental glomerulosclerosis	5.86e-05	0.000191	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	5.77e-05	0.000188	CbGpPWpGaD
Loperamide—CALM2—Disease—NOS2—focal segmental glomerulosclerosis	5.67e-05	0.000185	CbGpPWpGaD
Loperamide—CALM1—Disease—NOS2—focal segmental glomerulosclerosis	5.67e-05	0.000185	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	5.58e-05	0.000182	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—AGT—focal segmental glomerulosclerosis	5.52e-05	0.00018	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—LPL—focal segmental glomerulosclerosis	5.46e-05	0.000178	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	5.41e-05	0.000176	CbGpPWpGaD
Loperamide—CALM3—Metabolism—AGT—focal segmental glomerulosclerosis	5.37e-05	0.000175	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—LPL—focal segmental glomerulosclerosis	5.25e-05	0.000171	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	5.24e-05	0.000171	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	5.24e-05	0.000171	CbGpPWpGaD
Loperamide—CALM2—Metabolism—AGT—focal segmental glomerulosclerosis	5.2e-05	0.000169	CbGpPWpGaD
Loperamide—CALM1—Metabolism—AGT—focal segmental glomerulosclerosis	5.2e-05	0.000169	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	5.08e-05	0.000166	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—LPL—focal segmental glomerulosclerosis	5.08e-05	0.000166	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	5.06e-05	0.000165	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	4.97e-05	0.000162	CbGpPWpGaD
Loperamide—CALM3—Disease—SERPINE1—focal segmental glomerulosclerosis	4.93e-05	0.000161	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	4.81e-05	0.000157	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	4.81e-05	0.000157	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—LIPC—focal segmental glomerulosclerosis	4.81e-05	0.000157	CbGpPWpGaD
Loperamide—CALM2—Disease—SERPINE1—focal segmental glomerulosclerosis	4.77e-05	0.000155	CbGpPWpGaD
Loperamide—CALM1—Disease—SERPINE1—focal segmental glomerulosclerosis	4.77e-05	0.000155	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—LPL—focal segmental glomerulosclerosis	4.76e-05	0.000155	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	4.75e-05	0.000155	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—AGT—focal segmental glomerulosclerosis	4.67e-05	0.000152	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—AGT—focal segmental glomerulosclerosis	4.49e-05	0.000146	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—LPL—focal segmental glomerulosclerosis	4.49e-05	0.000146	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—AGT—focal segmental glomerulosclerosis	4.35e-05	0.000142	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	4.35e-05	0.000142	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	4.27e-05	0.000139	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—ALB—focal segmental glomerulosclerosis	4.24e-05	0.000138	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—CTGF—focal segmental glomerulosclerosis	4.23e-05	0.000138	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	4.17e-05	0.000136	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—FN1—focal segmental glomerulosclerosis	4.15e-05	0.000135	CbGpPWpGaD
Loperamide—CALM3—Metabolism—ALB—focal segmental glomerulosclerosis	4.12e-05	0.000134	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—AGT—focal segmental glomerulosclerosis	4.07e-05	0.000133	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	4.02e-05	0.000131	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—FN1—focal segmental glomerulosclerosis	4.02e-05	0.000131	CbGpPWpGaD
Loperamide—CALM2—Metabolism—ALB—focal segmental glomerulosclerosis	3.99e-05	0.00013	CbGpPWpGaD
Loperamide—CALM1—Metabolism—ALB—focal segmental glomerulosclerosis	3.99e-05	0.00013	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.9e-05	0.000127	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—AGT—focal segmental glomerulosclerosis	3.84e-05	0.000125	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—ALB—focal segmental glomerulosclerosis	3.59e-05	0.000117	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	3.52e-05	0.000115	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	3.45e-05	0.000113	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	3.34e-05	0.000109	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	3.34e-05	0.000109	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—ALB—focal segmental glomerulosclerosis	3.12e-05	0.000102	CbGpPWpGaD
Loperamide—CALM3—Disease—TGFB1—focal segmental glomerulosclerosis	3.11e-05	0.000101	CbGpPWpGaD
Loperamide—CALM1—Disease—TGFB1—focal segmental glomerulosclerosis	3.01e-05	9.82e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—TGFB1—focal segmental glomerulosclerosis	3.01e-05	9.82e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—ALB—focal segmental glomerulosclerosis	2.94e-05	9.59e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—LPL—focal segmental glomerulosclerosis	2.93e-05	9.56e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2.65e-05	8.62e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2.56e-05	8.34e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2.56e-05	8.34e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—AGT—focal segmental glomerulosclerosis	2.51e-05	8.17e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	2.18e-05	7.11e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	2.11e-05	6.87e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	2.11e-05	6.87e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—ALB—focal segmental glomerulosclerosis	1.93e-05	6.27e-05	CbGpPWpGaD
